Table 1 Clinical characteristics at baseline
Non-PCI (n = 38) | PCI (n = 126) | P value | |
|---|---|---|---|
Age, year | 67.2 ± 14.8 | 65.0 ± 13.5 | 0.237 |
Male | 22 (57.8) | 114 (90.4) | < 0.001 |
Onset to hospital time, hours | 57.0 ± 59.8 | 64.5 ± 76.2 | 0.574 |
Killip class | 0.003 | ||
1 | 23 (60.5) | 83 (65.9) | |
2 | 9 (23.7) | 33 (26.2) | |
3 | 4 (10.5) | 5 (4.0) | |
4 | 2 (5.3) | 5 (4.0) | |
cTnT, µg/L | 1198. 92 ± 777.63 | 1120.13 ± 743.78 | 0.348 |
SBP, mmHg | 129.8 ± 30.8 | 128.6 ± 25.5 | 0.830 |
DBP, mmHg | 74.7 ± 16.3 | 74.5 ± 14.10 | 0.956 |
Creatinine, umol/L | 147.1 ± 61.7 | 133.6 ± 51.9 | 0.180 |
eGFR, mL/min/1.73m2 | 47.1 ± 15.7 | 48.6 ± 13.9 | 0.650 |
Uric acid, umol/L | 449.2 ± 122.9 | 427.3 ± 125.2 | 0.350 |
Fasting glucose, mmol/L | 7.0 ± 3.5 | 7.6 ± 3.7 | 0.452 |
C-reactive protein, mg/L | 20.74 ± 32.39 | 18.51 ± 34.92 | 0.484 |
CK-MB, IU/L | 87.5 ± 120.3 | 91.8 ± 120.2 | 0.846 |
NT-proBNP, pg/mL | 8039.9 ± 7482.1 | 5069.9 ± 6552.3 | 0.155 |
Smoker | 16 (42.2) | 77 (61.1) | 0.147 |
Hyperlipidemia | 2 (5.3) | 16 (12.7) | 0.249 |
Hypertension | 19 (50.0) | 68 (54.0) | 0.052 |
Diabetes | 5 (13.2) | 18 (14.3) | 0.223 |
LVEDd, mm | 49.2 ± 5.5 | 49.30 ± 4.9 | 0.938 |
LVEF, % | 51.8 ± 10.3 | 53.30 ± 10.6 | 0.432 |